Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: A qualitative study of patients, caregivers and health workers

BMC Psychiatry

Volumn 13, Issue , 2013, Pages

  Teferra, Solomon ^a   Hanlon, Charlotte ^a,c   Beyero, Teferra ^a   Jacobsson, Lars ^b   Shibre, Teshome ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UMEÅ UNIVERSITY   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adherence; Antipsychotic; Ethiopia; Medication; Qualitative; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ACUTE DISEASE; ALCOHOL CONSUMPTION; ARTICLE; CAREGIVER; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG USE; ETHIOPIA; FOOD INSECURITY; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; POVERTY; QUALITATIVE RESEARCH; SCHIZOPHRENIA; SOCIAL SUPPORT; STIGMA; SUBSTANCE ABUSE; THEMATIC ANALYSIS; TREATMENT REFUSAL;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; CAREGIVERS; ETHIOPIA; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MEDICATION ADHERENCE; QUALITATIVE RESEARCH; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL STIGMA; SOCIAL SUPPORT;

EID: 84879038051     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-168     Document Type: Article

References (53)

1. Carpenter WT, Davis JM. PERSPECTIVE: another view of the history of antipsychotic drug discovery and development. Mol Psychiatry 2012, 17:1168-1173. 10.1038/mp.2012.121, 22889923.
2. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. Br Med J 1998, 317:1181-1184.
3. Teferra S, Shibre T, Fekadu A, Medhin G, Wakwoya A, Alem A, Jacobsson L. Five-year clinical course and outcome of schizophrenia in Ethiopia. Schizophr Res 2012, 136:137-142. 10.1016/j.schres.2011.10.021, 22104140.
4. Teferra S, Shibre T, Fekadu A, Medhin G, Wakwoya A, Alem A, Kullgren G, Jacobsson L. Five-year mortality in a cohort of people with schizophrenia in Ethiopia. BMC Psychiatry 2011, 11:165. 10.1186/1471-244X-11-165, 3207944, 21985179.
5. Alem A, Kebede D, Fekadu A, Shibre T, Fekadu D. Clinical course and outcome of schizophrenia in a predominantly treatment naïve cohort in Ethiopia. Schizophr Bull 2009, 35:646-654. 10.1093/schbul/sbn029, 2669573, 18448478.
6. Nosé M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programs? A systematic review. Psychol Med 2003, 33:1149-1160. 10.1017/S0033291703008328, 14580069.
7. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009, 70(suppl 4):1-46.
8. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002, 63:892-909. 10.4088/JCP.v63n1007, 12416599.
9. Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT. Medication adherence and quality of life among Nigerian outpatients with schizophrenia. Gen Hosp Psychiat 2012, 34:72-79.
10. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997, 23:637-651. 10.1093/schbul/23.4.637, 9366000.
11. Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry 1995, 52:173-188. 10.1001/archpsyc.1995.03950150005001, 7872841.
12. Dassa D, Boyer L, Benoit M, Bourcet S, Raymondet P, Bottai T. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system. Aust N Z J Psychiatry 2010, 44:921-928. 10.3109/00048674.2010.493503, 20932206.
13. Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M. Substance abuse and the management of medication nonadherence in schizophrenia. J Nerv Ment Dis 2006, 194:454-457. 10.1097/01.nmd.0000221289.54911.63, 16772865.
14. Barbui C, Kikkert M, Mazzi MA, Becker T, Bindaman J, Schene A, Nosè M, Helm H, Thornicroft G, Tensella M. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Psychopathology 2009, 42:311-317. 10.1159/000232973, 19672133.
15. Staring AB, Mulder CL, Duivenvoorden HJ, De Haan L, Van der Gaag M. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life. Schizophr Res 2009, 113:27-33. 10.1016/j.schres.2009.05.022, 19525092.
16. Breen A, Swartz L, Joska J, Flisher AJ, Corrigall J. Adherence to treatment in poorer countries: a new research direction?. Psychiatr Serv 2007, 58:567-568. 10.1176/appi.ps.58.4.567, 17412865.
17. Ministry of Health Federal Democratic Republic of Ethiopia National Mental Health Strategy 2011-2015 2012, Addis Ababa: Ethiopia MOH, Ministry of Health Federal Democratic Republic of Ethiopia.
18. World Health Organization Mental Health Gap Action Programme (mhGAP): Scaling up care for mental, neurological, and substance use disorders 2008, Geneva: UN World Health Organization, World Health Organization.
19. Kebede D, Alem A, Shibre T, Negash A, Fekadu A, Fekadu D, Deyassa N, Jacobsson L, Kullgren G. Onset and clinical course of schizophrenia in Butajira-Ethiopia: a community-based study. Soc Psych Psych Epid 2003, 38:625-631.
20. Alem A, Jacobsson L, Araya M, Kebede D, Kullgren G. How are mental disorders seen and where is help sought in a rural Ethiopian community? A key informant study in Butajira, Ethiopia. Acta Psychiatr Scnad 1999, 100:40-47.
21. Araya M, Mussie M, Jacobsson L. Decentralized psychiatric nursing service in Ethiopia-a model for low income countries. Ethiop Med J 2009, 47:61-64.
22. Kitzinger J. Qualitative Research: introducing focus groups. BMJ 1995, 311:299-302. 10.1136/bmj.311.7000.299, 2550365, 7633241.
23. Kikkert MJ, Schene AR, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ. Medication Adherence in Schizophrenia: Exploring Patients', Carers' and Professionals' Views. Schizophr Bull 2006, 32:786-794. 2632275, 16887889.
24. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006, 3:77-101.
25. Hanlon C, Medhin G, Alem A, Tesfaye F, Lakew Z, Worku B, Dewey M, Araya M, Abdulahi A, Hughes MT, Patel V, Prince M. Impact of antenatal common mental disorders upon perinatal outcomes in Ethiopia: the P-MaMiE population-based cohort study. Trop Med Int Health 2009, 14:156-166. 10.1111/j.1365-3156.2008.02198.x, 19187514.
26. Lijalem M, Tesfaye F, Alem A, Abera K, Kebede D. Nutrition status of cases of schizophrenia and bipolar disorders in Butajira, rural Ethiopia Addis Ababa 2003, MPH Thesis: Addis Ababa University, School of Public Health.
27. Orthen-Gambill N, Salomon M. Differential effects of psychotropic drugs on feeding in rats: is histamine blockade involved?. Pharmacol Biochem Behav 1990, 36:837-84. 10.1016/0091-3057(90)90086-W, 2217511.
28. Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004, 66:1-57. 10.1016/S0920-9964(02)00506-6, 14693347.
29. Harden AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 2007, 19:658-665. 10.1080/09540120701244943, 17505927.
30. Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, Tichacek A, Allen SA. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS 2006, 20:2116-2118. 10.1097/01.aids.0000247580.16073.1b, 17053359.
31. Teferra S, Hanlon C, Alem A, Jacobsson L, Shibre T. Khat chewing in persons with severe mental illness in Ethiopia: a qualitative study exploring perspectives of patients and caregivers. Transcult Psychiatry 2011, 48:455-472. 10.1177/1363461511408494, 21911510.
32. Arana GW. An Overview of Side Effects Caused by Typical Antipsychotics. J Clin Psychiatry 2000, 61(Suppl 8):5-11.
33. Farooq S, Nazar Z, Irfan M, Akhter J, Gul E, Irfan U, Naeem F. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS). Br J Psychiatry 2011, 199:467-472. 10.1192/bjp.bp.110.085340, 22130748.
34. Hanlon C, Tesfaye M, Wondimagegn D, Shibre T. Ethical and professional challenges in mental health care in low- and middle-income countries. Int Rev Psychiat 2010, 22:245-251.
35. Srinivasan TN, Thara R. At issue: management of medication noncompliance in schizophrenia by families in India. Schizophr Bull 2002, 28:531-535. 10.1093/oxfordjournals.schbul.a006960, 12645684.
36. Latha K. The Noncompliant Patient in Psychiatry: the Case For and Against Covert/Surreptitious Medication. Mens Sana Monogr 2010, 8:96-121. 10.4103/0973-1229.58822, 3031933, 21327173.
37. Shibre T, Medhin G, Teferra S, Wakwoya A, Berhanu E, Abdulahi A, Alem A, Fekadu A. Predictors of carer-burden in schizophrenia: a five-year follow-up study in Butajira, Ethiopia. Ethiop Med J 2012, 50:125-133.
38. Carder PC, Vuckovic N, Green CA. Negotiating medications: patient perceptions of long-term medication use. J Clin Pharm Ther 2003, 28:409-417. 10.1046/j.0269-4727.2003.00511.x, 14632966.
39. Shibre T, Negash A, Kullgren G, Kebede D, Alem A, Fekadu A, Fekadu D, Medhin G, Jacobsson L. Perception of stigma among family members of individuals with schizophrenia and major affective disorders in rural Ethiopia. Soc Psych Psych Epid 2001, 36:299-303.
40. Amador XF, Strauss DH. Poor insight in schizophrenia. Psychiat Quart 1993, 64:305-318. 10.1007/BF01064924, 8234544.
41. Lysaker PH, Clements CA, Plascak-Hallberg CD, Knipscheer SJ, Wright DE. Insight and Personal Narratives of Illness in Schizophrenia. Psychiatry 2002, 65:197-206.
42. Bartko G, Herczeg I, Zador G. Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatr Scand 1988, 77:74-76. 10.1111/j.1600-0447.1988.tb05080.x, 2894746.
43. Lysaker PH, Buck KD, Salvatore G, Popolo R, Dimaggio G. Lack of awareness of illness in schizophrenia: conceptualizations, correlates and treatment approaches. Expert Rev Neurother 2009, 9:1035-43. 10.1586/ern.09.55, 19589052.
44. Lysaker PH, Dimaggio G, Buck KD, Callaway SS, Salvatore G, Carcion A, Nicolò G, Stanghellini G. Poor insight in schizophrenia: links between different forms of metacognition with awareness of symptoms, treatment need, and consequences of illness. Compr Psychiat 2011, 52:253-260. 10.1016/j.comppsych.2010.07.007, 21497218.
45. Nageotte C, Sullivan G, Duan N, Camp PL. Medication compliance among the seriously mentally ill in a public mental health system. Soc Psych Psych Epid. 1997, 32:49-56.
46. Ruscher SM, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr Serv 1997, 48:82-85.
47. Velligan DI, Lam F, Ereshefsky L, Miller AL. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 2003, 54:665-667. 10.1176/appi.ps.54.5.665, 12719495.
48. Valenstein M, Blow FC, Copeland LA, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 2004, 30:255-264. 10.1093/oxfordjournals.schbul.a007076, 15279044.
49. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia relationship to course and outcome. Arch Gen Psychiatry 1990, 47:228-236. 10.1001/archpsyc.1990.01810150028006, 1968329.
50. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C. Attitudes toward antipsychotic medication the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 2005, 62:717-724. 10.1001/archpsyc.62.7.717, 15997012.
51. Hardeman SM, Harding RK, Narasimhan M. Simplifying adherence in schizophrenia. Psychiat Serv 2010, 61:405-408.
52. World Health Organization & Mental Health and Poverty Project Mental health and development: targeting people with mental health conditions as a vulnerable group 2010, Geneva: UN World Health Organization, World Health Organization & Mental Health and Poverty Project.
53. Ministry of Health Federal Democratic Republic of Ethiopia Country Progress Report on HIV/AIDS Response 2012 2012, Addis Ababa: Ethiopia MOH, Ministry of Health Federal Democratic Republic of Ethiopia.